首页> 美国卫生研究院文献>Scientific Reports >A new approach to obtain pure and active proteins from Lactococcus lactis protein aggregates
【2h】

A new approach to obtain pure and active proteins from Lactococcus lactis protein aggregates

机译:从乳酸乳球菌蛋白质聚集体中获得纯净和活性蛋白质的新方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The production of pure and soluble proteins is a complex, protein-dependent and time-consuming process, in particular for those prone-to-aggregate and/or difficult-to-purify. Although Escherichia coli is widely used for protein production, recombinant products must be co-purified through costly processes to remove lipopolysaccharide (LPS) and minimize adverse effects in the target organism. Interestingly, Lactococcus lactis, which does not contain LPS, could be a promising alternative for the production of relevant proteins. However, to date, there is no universal strategy to produce and purify any recombinant protein, being still a protein-specific process. In this context and considering that L. lactis is also able to form functional protein aggregates under overproduction conditions, we explored the use of these aggregates as an alternative source of soluble proteins. In this study, we developed a widely applicable and economically affordable protocol to extract functional proteins from these nanoclusters. For that, two model proteins were used: mammary serum amyloid A3 (M-SAA3) and metalloproteinase 9 (MMP-9), a difficult-to-purify and a prone-to-aggregate protein, respectively. The results show that it is possible to obtain highly pure, soluble, LPS-free and active recombinant proteins from L. lactis aggregates through a cost-effective and simple protocol with special relevance for difficult-to-purify or highly aggregated proteins.
机译:纯蛋白质和可溶性蛋白质的生产是一个复杂,依赖蛋白质且耗时的过程,特别是对于那些易于聚集和/或难以纯化的蛋白质而言。尽管大肠杆菌已广泛用于蛋白质生产,但重组产品必须通过昂贵的过程进行共纯化,以去除脂多糖(LPS)并最大程度降低对目标生物的不利影响。有趣的是,不含LPS的乳酸乳球菌可能是生产相关蛋白质的有前途的替代方法。然而,迄今为止,尚没有生产和纯化任何重组蛋白的通用策略,仍然是蛋白质特异性过程。在这种情况下,考虑到乳酸乳球菌也能够在生产过剩的条件下形成功能性蛋白质聚集体,我们探索了使用这些聚集体作为可溶性蛋白质的替代来源。在这项研究中,我们开发了一种广泛适用且经济实惠的方案,可从这些纳米簇中提取功能蛋白。为此,使用了两种模型蛋白:乳清血清淀粉样蛋白A3(M-SAA3)和金属蛋白酶9(MMP-9),它们分别是一种难以纯化的蛋白质和易于聚集的蛋白质。结果表明,可以通过具有成本效益的简单方案从乳酸乳球菌的聚集物中获得高度纯净,可溶,不含LPS的活性重组蛋白,该方案与难以纯化或高度聚集的蛋白特别相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号